platinum has been researched along with Drug-Induced Cochlear Toxicity in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 10 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brigato, F; De Corso, E; Fetoni, AR; Galli, J; Lucidi, D; Ruggiero, A; Scarano, E; Sergi, B | 1 |
| Ehlert, K; Graham, MA; Heinze, B; Swanepoel, D | 1 |
| Chadha, S; Dillard, LK; Fullerton, AM; Lopez-Perez, L; Martinez, RX; McMahon, CM | 1 |
| Ahmed, R; Attia, M; Hanna, D; Kamal, NM; Oshi, MAM; Rifky, E; Sherief, LM | 1 |
| Akeroyd, MA; Baguley, DM; Pearson, SE; Phillips, OR | 1 |
| Chong, WQ; Goh, BC; Hong, DZ; Kwa, ED; Loh, KS; Loh, WS; Ong, TCC; Tan, EC; Tan, HTA; Tay, JK; Timbadia, DP | 1 |
| Navarro-Ruiz, NE | 1 |
| Cunningham, LL; Fernandez, KA; Fitzgerald, TS; Gersten, BK | 1 |
| Burotto, M; Caglevic, C; Cortés Fuentes, IA; Frelinghuysen, M; Gormaz, JG; Retamal, MA | 1 |
| Allison, WT; Babolmorad, G; Bhavsar, AP; Delyea, C; Domingo, IK; Latif, A; Pollock, NM; Rieger, AM | 1 |
4 review(s) available for platinum and Drug-Induced Cochlear Toxicity
| Article | Year |
|---|---|
Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: A systematic review and meta-analysis.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Hearing Loss; Humans; Neoplasms; Ototoxicity; Platinum | 2022 |
The long-term impacts of hearing loss, tinnitus and poor balance on the quality of life of people living with and beyond cancer after platinum-based chemotherapy: a literature review.
Topics: Adult; Antineoplastic Agents; Cancer Survivors; Carboplatin; Child; Cisplatin; Hearing Loss; Humans; Neoplasms; Ototoxicity; Platinum; Quality of Life; Tinnitus | 2023 |
Systematic Review and Meta-Analysis of the Influence of Genetic Variation on Ototoxicity in Platinum-Based Chemotherapy.
Topics: Acid Anhydride Hydrolases; Antineoplastic Agents; Cisplatin; Humans; Ototoxicity; Platinum; Polymorphism, Single Nucleotide; Xeroderma Pigmentosum Group D Protein | 2023 |
Prevention of Platinum-Induced Hearing Loss in Children with Cancer.
Topics: Amifostine; Humans; Neoplasms; Ototoxicity; Platinum; Practice Guidelines as Topic; Thiosulfates | 2020 |
6 other study(ies) available for platinum and Drug-Induced Cochlear Toxicity
| Article | Year |
|---|---|
Long-term auditory follow-up in the management of pediatric platinum-induced ototoxicity.
Topics: Antineoplastic Agents; Carboplatin; Child; Cisplatin; Follow-Up Studies; Hearing Loss; Humans; Ototoxicity; Platinum; Platinum Compounds | 2022 |
Surveillance for ototoxicity in platinum-based chemotherapy using mobile health audiometry with extended high frequencies.
Topics: Antineoplastic Agents; Audiometry; Audiometry, Pure-Tone; Auditory Threshold; Cisplatin; Humans; Longitudinal Studies; Ototoxicity; Platinum | 2023 |
Platinum-induced ototoxicity in pediatric cancer survivors: GSTP1 c.313A>G variant association.
Topics: Cancer Survivors; Carboplatin; Child; Cisplatin; Cross-Sectional Studies; Deafness; Glutathione S-Transferase pi; Hearing Loss; Humans; Neoplasms; Ototoxicity; Platinum | 2022 |
Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents.
Topics: Animals; Antineoplastic Agents; Cisplatin; Cochlea; Female; Male; Mice, Inbred CBA; Ototoxicity; Platinum | 2020 |
Potential use of n-3 PUFAs to prevent oxidative stress-derived ototoxicity caused by platinum-based chemotherapy.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Fatty Acids, Omega-3; Humans; Ototoxicity; Oxidative Stress; Platinum | 2020 |
Toll-like receptor 4 is activated by platinum and contributes to cisplatin-induced ototoxicity.
Topics: Antineoplastic Agents; Cisplatin; Humans; Neoplasms; Ototoxicity; Platinum; Toll-Like Receptor 4 | 2021 |